Role of aldosterone availability in preeclampsia

Molecular Aspects of Medicine

Volumn 28, Issue 2, 2007, Pages 245-254

  Escher, Geneviève ^a   Mohaupt, Markus ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aldosterone; CYP11B2; Mineralocorticoid receptor; Preeclampsia

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; HYDROCORTISONE; MINERALOCORTICOID RECEPTOR; PROGESTERONE; SODIUM;

BLOOD PRESSURE REGULATION; BODY FLUID; HUMAN; PREECLAMPSIA; PREGNANCY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK FACTOR; SODIUM ABSORPTION; WELLBEING;

ALDOSTERONE; ALDOSTERONE SYNTHASE; BLOOD PRESSURE; FEMALE; HUMANS; MODELS, BIOLOGICAL; PRE-ECLAMPSIA; PREGNANCY;

EID: 34249675786     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.03.002     Document Type: Review

References (29)

1. Broughton Pipkin F. Risk factors for preeclampsia. New Engl. J. Med. 22 344 (2001) 925-926
2. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 (2005) 565
3. Dunn J.F., Nisula B.C., and Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J. Clin. Endocrinol. Metab. 53 (1981) 58-68
4. Funder J.W., Pearce P.T., Smith R., and Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242 (1988) 583-585
5. Gallery E.D., and Brown M.A. Control of sodium excretion in human pregnancy. Am. J. Kidney Dis. 9 (1987) 290-295
6. Gallery E.D., Hunyor S.N., and Gyrory A.Z. Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Quart. J. Med. 48 (1979) 593-602
7. Gallery E.D.M., Mitchell M.D., and Redman C.W.G. Fall in blood pressure in response to volume expansion in pregnancy-associated hypertension: Why does it occur?. J. Hypertens. 2 (1984) 177-182
8. Gant N.F., Daley G.L., Chand S., Whalley P.J., and MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J. Clin. Invest. 52 (1973) 2682-2689
9. GOPEC Consortium. Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study. Am. J. Hum. Genet. 77 (2005) 127-131
10. Herse F., Dechend R., Harsem N.K., Wallukat G., Janke J., Qadri F., Hering L., Muller D.N., Luft F.C., and Staff A.C. Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 49 (2007) 604-611
11. Johansson E.D., and Jonasson L.E. Progesterone levels in amniotic fluid and plasma from women. I. Levels during normal pregnancy. Acta Obstet. Gynecol. Scand. 50 (1971) 339-343
12. Lesky E. The haematological system. In: Hytten F., and Chamberlain G. (Eds). Clinical Physiology in Obstetrics (1980), Blackwell Scientific Publications, Oxford 43-78
13. Li D.K., and Wi S. Changing paternity and the risk of preeclampsia/eclampsia in the subsequent pregnancy. Am. J. Epidemiol. 151 (2000) 57-62
14. Longo L.D. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am. J. Physiol. 245 (1983) R720-R729
15. Myles K., and Funder J.W. Progesterone binding to mineralocorticoid receptors: in vitro and in vivo studies. Am. J. Physiol. 270 (1996) E601-E607
16. Pirani B.B., Campbell D.M., and MacGillivray I. Plasma volume in normal first pregnancy. J. Obstet. Gynaecol. Br. Commonw. 80 (1973) 884-887
17. Poisner A.M. The human placental renin-angiotensin system. Front. Neuroendocrinol. 19 (1998) 232-252
18. Pojoga L., Gautier S., Blanc H., Guyene T.T., Poirier O., Cambien F., and Benetos A. Genetic determination of plasma aldosterone levels in essential hypertension. Am. J. Hypertens. 11 (1998) 856-860
19. Portrat-Doyen S., Tourniaire J., Richard O., Mulatero P., Aupetit-Faisant B., Curnow K.M., Pascoe L., and Morel Y. Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J. Clin. Endocrinol. Metab. 83 (1998) 4156-4161
20. Quinkler M., Johanssen S., Grossmann C., Bähr V., Müller M., Oelkers W., and Diederich S. Progesterone metabolism in the human kidney and inhibition of 11β-hydroxysteroid dehydrogenase type 2 by progesterone and its metabolites. J. Clin. Endocrinol. Metab. 84 (1999) 4165-4171
21. Roberts J.M., and Coopr D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 357 (2001) 53-56
22. Salas S.P., Marshall G., Gutierrez B.L., and Rosso P. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 47 (2006) 203-208
23. Schmider-Ross A., Wirsing M., Buscher U., Neitzel H., Krause M., Henrich W., Reles A., and Dudenhausen J.W. Analysis of the S810L point mutation of the mineralocorticoid receptor in patients with pregnancy-induced hypertension. Hypertens. Pregnancy 23 (2004) 113-119
24. Shojaati K., Causevic M., Kadereit B., Dick B., Imobersteg J., Schneider H., Beinder E., Kashiwagi M., Frey B.M., and Frey F.J. Evidence for compromised aldosterone synthase enzyme activity in preeclampsia. Kidney Int. 66 (2004) 2322-2328
25. 18 substituent. Endocrinology 136 (1995) 5651-5658
26. Spinnato J.A. New therapies in the prevention of preeclampsia. Curr. Opin. Obstet. Gynecol. 18 (2006) 601-604
27. Symonds E.M., Broughton Pipkin F., and Craven D.J. Changes in the renin-angiotensin system in primigravidae with hypertensive disease of pregnancy. Br. J. Obstet. Gynaecol. 82 (1975) 643-650
28. Tomkins A. Nutrition and maternal morbidity and mortality. Br. J. Nutr. 85 (2001) S93-S99
29. Walker J.J. Preeclampsia. Lancet 356 (2000) 1260-1265